ArriVent BioPharma Reports Second Quarter 2024 Financial Results
Go back to ArriVent BioPharma Reports Second Quarter 2024 Financial Results| (NASDAQ: AVBP) | Delayed: 30.51 +0.36 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.15 | 52 Week High | $ | |||
| Open | $30.33 | 52 Week Low | $ | |||
| Day High | $30.79 | P/E | N/A | |||
| Day Low | $29.60 | EPS | $ | |||
| Volume | 423,868 | |||||
| (NASDAQ: IMCR) | Delayed: 37.37 +0.51 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.86 | 52 Week High | $ | |||
| Open | $37.17 | 52 Week Low | $ | |||
| Day High | $37.95 | P/E | N/A | |||
| Day Low | $36.23 | EPS | $ | |||
| Volume | 220,689 | |||||
